Lawyers in our Mass Torts Section who are handling the Invokana litigation are pleased that the Panel has chosen to centralize. Read more
Lawyers in Beasley Allen’s Mass Torts Section are investigating claims on behalf of individuals and families injured by Invokana and Invokamet. Read more
A similar clinical trial that has followed patients for nine months hasn’t found the same elevated risks of amputation, the FDA said. Read more
The U.S. Food and Drug Administration (FDA) has strengthened its warning for Invokana (canagliflozin, Invokamet, Johnson & Johnson/Janssen Pharmaceuticals Inc.) related to the increased... Read more
Johnson & Johnson’s Invokana, approved by the U.S. Food and Drug Administration (FDA) in March 2013, is prescribed to people with Type 2 diabetes. When Invokana was approved, it was the... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.